Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results
Winni Maharani,1,2 Dwi Febni Ratnaningsih,3 Fitria Utami,3 Fajar Awalia Yulianto,4 Anneke Dewina,5 Laniyati Hamijoyo,5,6 Nur Atik5,7 1Department of Microbiology, Faculty of Medicine, Universitas Islam Bandung, Bandung, Indonesia; 2Biomedical Sciences Master Program, Faculty of Medicine, Padjadjaran...
Guardado en:
Autores principales: | Maharani W, Ratnaningsih DF, Utami F, Yulianto FA, Dewina A, Hamijoyo L, Atik N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/75546f101017407ba4e52b1f2b23909f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef AA, et al.
Publicado: (2020) -
Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
por: Yousef AA, et al.
Publicado: (2021) -
Role of IFN and Complements System: Innate Immunity in SARS-CoV-2
por: Shibabaw T, et al.
Publicado: (2020) -
Autoimmune Thrombocytopenia in SLE and COVID-19
por: Yeremia Suryo Pratama, et al.
Publicado: (2021) -
Synergistic induction of CX3CL1 by TNF alpha and IFN gamma in osteoblasts from rheumatoid arthritis: involvement of NF-kappa B and STAT-1 signaling pathways
por: Kuninobu Wakabayashi, et al.
Publicado: (2008)